https://orcid.org/0000-0002-8340-8866
Figures & data
Table 1 Basic Information on CRKP Isolates in Zunyi, China
Table 2 Antimicrobial Susceptibility of 94 CRKP Isolates
Table 3 The Occurrence of MDR, XDR and PDR Among the CRKP Isolates
Figure 1 Representative images of mCIM and eCIM test results. (A) mCIM test results; (B) eCIM test results. 1: ATCC®BAA-1705TM (producing serine carbapenemase) as a positive control; 2: CRKP clinical isolates (producing serine carbapenemase); 3: ATCC®BAA-2146TMa (producing metallo-β-lactamase) as a positive control; 4: CRKP clinical isolates (producing metallo-β-lactamase).
Figure 2 Prevalence of carbapenemase genes in CRKP isolates and the consistency between genotypes and phenotypes of the isolates.
Figure 3 Prevalence of virulence genes in the CRKP isolates.
Figure 4 Prevalence of carbapenemase genes in isolates from children and adults.
Figure 5 Sequence types of the CRKP isolates.
Figure 6 The proportion of carbapenemase genes in the top three CRKP STs.
Figure 7 Antimicrobial susceptibility of the top three STs. *P <0.05, ***P <0.001.
